Expression of mIRNA-142-3P in Peripheral Blood From Active and Latent Pulmonary Tuberculosis
DOI:
https://doi.org/10.52783/jns.v14.1588Keywords:
Tuberculosis, Pulmonary, Peripheral Blood, Mycobacterial InfectionsAbstract
This study aimed to asses miRNA-142-3p expression of active and latent pulmonary tuberculosis. 33 people with active Tuberculosis (TB), 36 household contacts who tested positive for IFN-released assay (IGRA), and 39 healthy controls made up this case-control study. Latent pulmonary tuberculosis infection in household contacts was identified using an IGRA based on an enzyme-linked immunosorbent test. miRNA-142-3p expression was measured by quantitative real-time PCR. Data analysis used analysed of variance and receiver operating characteristic (ROC) curves. The results showed that miRNA-142-3p expression differed significantly between active TB, latent TB and healthy participans (control p=<0.001). ROC curve analysis showed that miRNA-142-3p expression had 66.7% sensitivity and 61.5% specificity with an area under the ROC curve (AUC) of 0.725 ( 95% confidence interval (CI): 0.606 – 0.844) in active TB. The miRNA-142-3p ROC curve had 63.9% sensitivity and 51.3% specificity with an area under the ROC curve (AUC) of 0.603 (95% confidence interval (CI): 0.475 - 0.730) for laten TB. miRNA-142-3p expression was increased in patients with active pulmonary TB. Therefore, miRNA-142-3p represents a potential biomarker active pulmonary TB but not to latent TB.
Downloads
Metrics
References
WHO. Global Tuberculosis report [Internet]. 2022. Available from: http://apps.who.int/bookorders.
Behrouzi A, Alimohammadi M, Nafari AH, Yousefi MH, Rad FR, Vaziri F, et al. The role of host mirnas on mycobacterium tuberculosis. ExRNA. 2019;1(October-November-December):1–10.
3. De La Garza Ramos R, Goodwin CR, Abu-Bonsrah N, Bydon A, Witham TF, Wolinsky JP, et al. The epidemiology of spinal tuberculosis in the United States: An analysis of 2002-2011 data. J Neurosurg Spine. 2017;26(4):507–12.
Lin WC, Lin HH, Lee SSJ, Sy CL, Wu KS, Chen JK, et al. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-b. Journal of Microbiology, Immunology and Infection [Internet]. 2016;49(5):729–36. Available from: http://dx.doi.org/10.1016/j.jmii.2014.08.010
Zhou M, Yu G, Yang X, Zhu C, Zhang Z, Zhan X. Circulating microRNAs as biomarkers for the early diagnosis of childhood tuberculosis infection. Mol Med Rep. 2016;13(6):4620–6.
Wu LSH, Lee SW, Huang KY, Lee TY, Hsu PWC, Weng JTY. Systematic Expression Profiling Analysis Identifies Specific MicroRNA-Gene Interactions that May Differentiate between Active and Latent Tuberculosis Infection. Biomed Res Int. 2014;2014.
Latorre I, Leidinger P, Backes C, Domínguez J, De Souza-Galvão ML, Maldonado J, et al. A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis. European Respiratory Journal. 2015;45(4):1173–6.
Wang JX, Xu J, Han YF, Zhu YB, Zhang WJ. Diagnostic values of microRNA-31 in peripheral blood mononuclear cells for pediatric pulmonary tuberculosis in Chinese patients. Genetics and Molecular Research. 2015 Dec 16;14(4):17235–43.
Qi Y, Cui L, Ge Y, Shi Z, Zhao K, Guo X, et al. Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection. BMC Infect Dis. 2012 Dec 28;12.
Fu Y, Yi Z, Wu X, Li J, Xu F. Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol. 2011;49(12):4246–51.
Kleinsteuber K, Heesch K, Schattling S, Kohns M, Sander-Jülch C, Walzl G, et al. Decreased Expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4+ T Cells and Peripheral Blood from Tuberculosis Patients. PLoS One. 2013 Apr 16;8(4).
Wang C, Yang S, Sun G, Tang X, Lu S, Neyrolles O, et al. Comparative mirna expression profiles in individuals with latent and active tuberculosis. PLoS One. 2011;6(10).
Lyu L, Zhang X, Li C, Yang T, Wang J, Pan L, et al. Small RNA profiles of serum exosomes derived from individuals with latent and active tuberculosis. Front Microbiol. 2019;10(MAY).
Hashimoto S, Zhao H, Hayakawa M, Nakajima K, Taguchi Y h, Murakami Y. Developing a diagnostic method for latent tuberculosis infection using circulating miRNA. Transl Med Commun. 2020 Dec;5(1).
Xu J, Li CX, Li YS, Lv JY, Ma Y, Shao TT, et al. MiRNA-miRNA synergistic network: Construction via co-regulating functional modules and disease miRNA topological features. Nucleic Acids Res. 2011 Feb;39(3):825–36.
Wuchty S, Arjona D, Bozdag S, Bauer PO. Involvement of microRNA families in cancer. Nucleic Acids Res. 2012 Sep;40(17):8219–26.
Chang KH, Mestdagh P, Vandesompele J, Kerin MJ, Miller N. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer. 2010 Apr 29;10.
Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C, et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer. 2012 Apr 1;130(7):1620–8.
Cortez MA, Welsh JW, Calin GA. Circulating MicroRNAs as noninvasive biomarkers in breast cancer. Recent Results in Cancer Research. 2012;195:151–61.
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008 Oct;18(10):997–1006.
Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers. PLoS One. 2008 Sep 5;3(9).
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Vol. 105, PNAS. 2008.
Saltini C. Chemotherapy and diagnosis of tuberculosis. Respir Med. 2006 Dec;100(12):2085–97.
Miotto P, Mwangoka G, Valente IC, Norbis L, Sotgiu G, Bosu R, et al. MiRNA signatures in sera of patients with active pulmonary tuberculosis. PLoS One. 2013 Nov 21;8(11).
Sampath P, Periyasamy KM, Ranganathan UD, Bethunaickan R. Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis. Vol. 12, Frontiers in Immunology. Frontiers Media S.A.; 2021.
Bettencourt P, Marion S, Pires D, Santos LF, Lastrucci C, Carmo N, et al. Actin-binding protein regulation by micrornas as a novel microbial strategy to modulate phagocytosis by host cells: The case of N-Wasp and miR-142-3p. Front Cell Infect Microbiol. 2013;4(JUN).
Qu Y, Gao Q, Wu S, Xu T, Jiang D, Xu G. MicroRNA-142-3p inhibits autophagy and promotes intracellular survival of Mycobacterium tuberculosis by targeting ATG16L1 and ATG4c. Int Immunopharmacol. 2021 Dec 1;101.
Xu G, Zhang Z, Wei J, Zhang Y, Zhang Y, Guo L, et al. MicroR-142-3p down-regulates IRAK-1 in response to Mycobacterium bovis BCG infection in macrophages. Tuberculosis [Internet]. 2013;93(6):606–11. Available from: http://dx.doi.org/10.1016/j.tube.2013.08.006
Rothchild AC, Sissons JR, Shafiani S, Plaisier C, Min D, Mai D, et al. MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6172–81.
Gao SH, Chen CG, Zhuang CB, Zeng YL, Zeng ZZ, Wen PH, et al. Integrating serum microRNAs and electronic health records improved the diagnosis of tuberculosis. J Clin Lab Anal. 2021 Aug 1;35(8).
Wallis RS, Kim P, Cole S, Hanna D, Andrade BB, Maeurer M, et al. Tuberculosis biomarkers discovery: Developments, needs, and challenges. Vol. 13, The Lancet Infectious Diseases. 2013. p. 362–72.
Backes C, Meese E, Keller A. Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects. Mol Diagn Ther. 2016 Dec 1;20(6):509–18.
Xu W, Zhou Y, Xu G, Geng B, Cui Q. Transcriptome analysis reveals non-identical microRNA profiles between arterial and venous plasma [Internet]. 2017. Available from: www.impactjournals.com/oncotarget
Alipoor SD, Adcock IM, Tabarsi P, Folkerts G, Mortaz E. MiRNAs in tuberculosis: Their decisive role in the fate of TB. Eur J Pharmacol [Internet]. 2020;886(September):173529. Available from: https://doi.org/10.1016/j.ejphar.2020.173529
Febriza A, Natzir R, Hatta M, Alam G, Kasim VN, Idrus HH. Curcumin effects in inducing mRNA gene cathelidicin antimicrobial peptide in Balb/c mice infected with Salmonella typhi.
Kasim V, Hatta M, Natzir R, Hadju V, Febriza A, Idrus H. Effects of lime (Citrus aurantifolia) peel to the expression of mRNA toll-like receptors 4 in balb/c mice-infected Salmonella typhi. J Adv Pharm Technol Res. 2020;11(4):169.
Sunarno S, Puspandari N, Fitriana F, Nikmah UA, Idrus HH, Panjaitan NSD. Extended spectrum beta lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in Indonesia and South East Asian countries: GLASS Data 2018. AIMSMICRO. 2023;9(2):218–27.
Febriza A, Hatta M, Natzir R, Kasim VNA, Idrus HH. Activity of Antimicrobial Peptide; Cathelicidin, on Bacterial Infection. TOBIOCJ. 2019 Jun 30;13(1):45–53.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
